Your browser doesn't support javascript.
loading
Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release.
Ma, Yue; Ratnasabapathy, Risheka; De Backer, Ivan; Izzi-Engbeaya, Chioma; Nguyen-Tu, Marie-Sophie; Cuenco, Joyceline; Jones, Ben; John, Christopher D; Lam, Brian Yh; Rutter, Guy A; Yeo, Giles Sh; Dhillo, Waljit S; Gardiner, James.
Affiliation
  • Ma Y; Section of Endocrinology and Investigative Medicine and.
  • Ratnasabapathy R; Section of Endocrinology and Investigative Medicine and.
  • De Backer I; Section of Endocrinology and Investigative Medicine and.
  • Izzi-Engbeaya C; Section of Endocrinology and Investigative Medicine and.
  • Nguyen-Tu MS; Section of Cell Biology and Functional Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
  • Cuenco J; Section of Endocrinology and Investigative Medicine and.
  • Jones B; Section of Endocrinology and Investigative Medicine and.
  • John CD; Section of Endocrinology and Investigative Medicine and.
  • Lam BY; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Rutter GA; Section of Cell Biology and Functional Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
  • Yeo GS; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Dhillo WS; Section of Endocrinology and Investigative Medicine and.
  • Gardiner J; Section of Endocrinology and Investigative Medicine and.
JCI Insight ; 5(8)2020 03 31.
Article in En | MEDLINE | ID: mdl-32229720
ABSTRACT
Glucokinase (GK) is highly expressed in the hypothalamic paraventricular nucleus (PVN); however, its role is currently unknown. We found that GK in the PVN acts as part of a glucose-sensing mechanism within the PVN that regulates glucose homeostasis by controlling glucagon-like peptide 1 (GLP-1) release. GLP-1 is released from enteroendocrine L cells in response to oral glucose. Here we identify a brain mechanism critical to the release of GLP-1 in response to oral glucose. We show that increasing expression of GK or injection of glucose into the PVN increases GLP-1 release in response to oral glucose. On the contrary, decreasing expression of GK or injection of nonmetabolizable glucose into the PVN prevents GLP-1 release. Our results demonstrate that gluco-sensitive GK neurons in the PVN are critical to the response to oral glucose and subsequent release of GLP-1.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraventricular Hypothalamic Nucleus / Glucagon-Like Peptide 1 / Glucose Limits: Animals Language: En Journal: JCI Insight Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraventricular Hypothalamic Nucleus / Glucagon-Like Peptide 1 / Glucose Limits: Animals Language: En Journal: JCI Insight Year: 2020 Document type: Article